Tick-Borne Encephalitis (FSME) Vaccine
Tick-Borne Encephalitis (TBE) is a viral infection that attacks the central nervous system and can result in serious meningitis, brain inflammation and in some instances death. Travellers who spend time in regions where TBE is endemic may be at risk. The highest risk is during the warmer months from April to November, especially when hiking or camping in areas below 1500m. Ticks climb onto grass and other vegetation then latch onto animals and humans as they pass by. The TBE virus is transmitted to humans through the bite of infected tick of the Ixodes species.
Ticks may breed around homes and in local parks too. Humans are often unaware that they have been bitten.
Tick-Borne Encephalitis (TBE) is caused by three different virus sub-types: European, Far Eastern and Siberian and endemic in regions of at least 27 European countries, parts of Central and Eastern Asia including Northern Japan and Northern China. Risk areas have expanded over the past 3 years and TBE now represents a significant public health concern for many regions in Europe and beyond.
Although there is no treatment for TBE, there is a vaccine that can be used as a preventative measure against the disease. The vaccination is not yet licensed in Australia, however for information regarding sourcing the Tick-borne Encephalitis vaccine for use in Australia, contact us today
